EFFECTS OF BIOLOGIC THERAPY IN PRIMARY SCLEROSING CHOLANGITIS WITH AND WITHOUT INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Callaghan, Gavin B.
Shah, Ayesha
Fairlie, Thomas
Jones, Michael P.
Holtmann, Gerald J.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1142
引用
收藏
页码：S299 / S300
页数：2
相关论文
共 50 条
  • [31] BIOLOGIC INDUCED HEPATOTOXICITY IN INFLAMMATORY BOWEL DISEASE (IBD); A SYSTEMATIC REVIEW AND META-ANALYSIS
    Gadour, Eyad
    Hassan, Zeinab
    GUT, 2021, 70 : A105 - A106
  • [32] Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Khan, Khurram J.
    Ullman, Thomas A.
    Ford, Alexander C.
    Abreu, Maria T.
    Abadir, A.
    Marshall, John K.
    Talley, Nicholas J.
    Moayyedi, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04): : 661 - 673
  • [33] Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
    Ford, Alexander C.
    Bernstein, Charles N.
    Khan, Khurram J.
    Abreu, Maria T.
    Marshall, John K.
    Talley, Nicholas J.
    Moayyedi, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04): : 590 - 599
  • [34] BIOLOGIC INDUCED HEPATOTOXICITY IN INFLAMMATORY BOWEL DISEASE (IBD); A SYSTEMATIC REVIEW AND META-ANALYSIS
    Gadour, Eyad
    Hassan, Zeinab
    GUT, 2021, 70 : A10 - A10
  • [35] The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review
    Arbabzada, Naik
    Dennett, Liz
    Meng, Guanmin
    Peerani, Farhad
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [36] Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis
    Korkmaz, Kerem Sebib
    Steenstraten, Iris
    Trivedi, Palak
    Inderson, Akin
    Van Hoek, Bart
    Girondo, Mar Rodriguez
    Maljaars, Jeroen
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E414 - E414
  • [37] Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis
    Steenstraten, I.
    Korkmaz, K. Sebib
    Trivedi, P.
    Inderson, A.
    van Hoek, B.
    Girondo, M. Rodriguez
    Maljaars, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S302 - S303
  • [38] Immunosuppressive Agents for the Treatment of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis
    Peng, Xia
    Luo, Xin
    Hou, Jing-Ying
    Wu, Shu-Yun
    Li, Liang-Zong
    Zheng, Ming-Hua
    Wang, Ling-Yun
    DIGESTIVE DISEASES, 2017, 35 (05) : 478 - 485
  • [39] Ursodeoxycholic Acid and Risk of Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Meta-Analysis
    Singh, Siddharth
    Khanna, Sahil
    Pardi, Darrell
    Loftus, Edward
    Talwalkar, Jayant
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S29 - S30
  • [40] Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis
    Liu, Xin
    Wang, Haolu
    Liu, Xinyao
    Bridle, Kim
    Crawford, Darrell
    Liang, Xiaowen
    PHARMACOLOGY & THERAPEUTICS, 2022, 237
12345